Fox Chase Honors "Wing" Pepper, Announces Endowed Faculty Chair in His Name
PHILADELPHIA (January 8, 1999) -- As part of the $38 million campaign to launch Fox Chase Cancer Center's new Research Institute for Cancer Prevention, Center staff and faculty are preparing to honor board member emeritus G. Willing "Wing" Pepper of Media, Pa. A reception in his honor will take place at the Center on Wednesday, January 13, when Fox Chase president Dr. Robert C. Young of the city's Chestnut Hill section will announce the endowment of the G. Willing "Wing" Pepper Chair in Cancer Research.
Pepper, 91, was instrumental in the growth of Fox Chase as one of the first comprehensive cancer centers designated by the National Cancer Institute in 1974. He joined the Fox Chase board in 1973, shortly after retiring as president and chief executive officer of Scott Paper Company.
The special tea in his honor is part of the "family campaign" by the staff, whose goal is to obtain commitments for $1 million in pledges for the Research Institute for Cancer Prevention by September 1999. The $38 million initiative in cancer prevention research will add state-of-the-art laboratories as well as new research programs that will be housed in the five-level, 120,000-square-foot Prevention Pavilion on Fox Chase's main campus.
The new prevention programs and laboratory space will add more than 100 members to Fox Chase's scientific and medical staff as well as additional support staff. Of those positions, six will be for endowed senior faculty chairs and three for endowed postdoctoral fellowships.
Among the six endowed chairs, the new Wing Pepper Chair joins the Carol and Kenneth Weg Chair in Human Genetics, endowed by board member Kenneth Weg of Princeton, N.J., and the William Wikoff Smith Chair in Cancer Research, endowed by the W. W. Smith Charitable Trust of Newtown Square, Pa.
Fox Chase Cancer Center is one of 35 National Cancer Institute-designated comprehensive cancer centers in the nation. The Center's activities include basic and clinical research, prevention, detection and treatment of cancer and community outreach programs.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy Moore at 215-728-2700.